BREZTRI AEROSPHERE
PeakNDAINHALATIONAEROSOL, METERED
Approved
Jul 2020
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
1
Data completeness
5/8 — Partial
Drug data last refreshed 14h ago · AI intelligence enriched Yesterday
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
BREZTRI AEROSPHERE is a metered-dose aerosol inhaler approved by the FDA in July 2020 for chronic respiratory disease management. The product is a small-molecule combination delivered via inhalation, designed for patients requiring multi-component maintenance therapy. Specific mechanism of action and indication details are proprietary, but the aerosol formulation targets optimal lung delivery.
$0.8BPart D
PeakStable
11.9 years to LOEAt peak lifecycle with $796M in Part D spending (2023) and nearly 1M claims, indicating mature market presence and likely stable-to-growing commercial team focused on market share defense and provider relationship management.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive Pulmonary Disease
Started Jan 2026
166 enrolled
Moderate to Severe COPD
Why This Matters for Your Career
Worked on BREZTRI AEROSPHERE at AstraZeneca? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.